0R29 Stock Chart & Stats
$371.90
$0.94(0.26%)
At close: 4:00 PM EDT
$371.90
$0.94(0.26%)
Day’s Range― - ―
52-Week Range$328.37 - $603.32
Previous CloseN/A
Volume48.00
Average Volume (3M)2.71K
Market Cap
$154.56B
Enterprise Value$139.03B
Total Cash (Recent Filing)$4.04B
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)53.3
Beta0.74
Next Earnings
Jan 26, 2027EPS Estimate
2.95Next Dividend Ex-DateN/A
Dividend Yield0.11%
Share Statistics
EPS (TTM)8.37
Shares Outstanding346,643,700
10 Day Avg. Volume3,520
30 Day Avg. Volume2,708
Financial Highlights & Ratios
PEG Ratio3.17
Price to Book (P/B)11.34
Price to Sales (P/S)20.08
P/FCF Ratio81.16
Enterprise Value/Market Cap0.90
Enterprise Value/Revenue12.01
Enterprise Value/Gross Profit17.87
Enterprise Value/Ebitda33.18
Forecast
1Y Price Target
$498.26Price Target Upside33.98% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering20
EPS Forecast (FY)11.2
Revenue Forecast (FY)$11.91B
Bulls Say, Bears Say
Bulls Say
Recurring Revenue ModelThe large recurring revenue mix links growth to the installed base and procedure utilization rather than only new system sales. Rising instruments, accessories, and service revenue should support visibility, customer retention, and durable cash generation as adoption expands.
Installed Base And Global AdoptionA broad installed base and global customer network create durable switching benefits through training, service relationships, and procedure familiarity. This footprint also provides a foundation for recurring consumables revenue and further utilization growth across specialties and geographies.
Conservative Balance SheetEssentially debt-free finances give Intuitive substantial flexibility to fund product development, international expansion, and capital returns without material refinancing or interest burden. The strong equity base also improves resilience if healthcare demand or operating conditions become less favorable.
Bears Say
Revenue Per Procedure PressureLower revenue per procedure directly challenges the economics of the company’s recurring consumables model, even if procedure volumes continue to grow. The pressure will roll out across countries and may constrain revenue growth and margins until adoption gains or new products offset it.
Regional Growth HeadwindsSlower U.S. procedure growth can moderate utilization of the large domestic installed base, while weaker Chinese conditions may delay placements and consumables expansion. These regional headwinds could make future growth more dependent on international execution and newer procedure categories.
Higher Operating CostsFaster expense growth can reduce operating leverage if revenue expansion slows or development programs take longer to commercialize. Continued investment is strategically important, but higher compensation, staffing, and prototype costs create a sustained risk to margin progression.
Intuitive Surgical News
0R29 FAQ
What was Intuitive Surgical’s price range in the past 12 months?
Intuitive Surgical lowest share price was $328.37 and its highest was $603.32 in the past 12 months.
What is Intuitive Surgical’s market cap?
Intuitive Surgical’s market cap is $154.56B.
When is Intuitive Surgical’s upcoming earnings report date?
Intuitive Surgical’s upcoming earnings report date is Jan 26, 2027 which is in 89 days.
How were Intuitive Surgical’s earnings last quarter?
Intuitive Surgical released its earnings results on Oct 20, 2026. The company reported $3 earnings per share for the quarter, beating the consensus estimate of $2.646 by $0.354.
Is Intuitive Surgical overvalued?
According to Wall Street analysts Intuitive Surgical’s price is currently Undervalued.
Does Intuitive Surgical pay dividends?
Intuitive Surgical pays a Notavailable dividend of $0.285 which represents an annual dividend yield of 0.11%. See more information on Intuitive Surgical dividends here
What is Intuitive Surgical’s EPS estimate?
Intuitive Surgical’s EPS estimate is 2.95.
How many shares outstanding does Intuitive Surgical have?
Intuitive Surgical has 346,643,700 shares outstanding.
What happened to Intuitive Surgical’s price movement after its last earnings report?
Intuitive Surgical reported an EPS of $3 in its last earnings report, beating expectations of $2.646. Following the earnings report the stock price went down -2.081%.
Which hedge fund is a major shareholder of Intuitive Surgical?
Currently, no hedge funds are holding shares in GB:0R29
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Intuitive Surgical Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$498.26 (33.98% Upside)
$498.26 (33.98% Upside)
Blogger Sentiment
Bullish
GB:0R29 Sentiment 83%
Sector Average 65%
Sector Average 65%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-19.11%
12-Months-Change
Fundamentals
Return on Equity
17.03%
Trailing 12-Months
Asset Growth
-0.01%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Intuitive Surgical
Intuitive Surgical, Inc. is a leading medical technology firm dedicated to advancing patient care by developing, producing, and commercializing sophisticated tools. These innovations empower medical professionals to deliver superior, accessible, and less-invasive treatment options to patients both within the United States and across international markets. Its flagship offering, the da Vinci Surgical System, facilitates intricate operations through a minimally disruptive approach. Expanding beyond surgical applications, the company also provides the Ion endoluminal system, designed for diagnostic interventions like minimally invasive lung biopsies. Complementing its primary systems, Intuitive Surgical supplies a comprehensive array of instruments, including stapling tools, energy devices, and essential core components. Furthermore, it offers structured training programs to ensure proficient use of its technology, alongside extensive customer support services encompassing installation, repairs, and ongoing maintenance. The firm also integrates digital capabilities to deliver unified, connected solutions that optimize hospital performance through actionable insights. Established in 1995, Intuitive Surgical maintains its corporate headquarters in Sunnyvale, California.
0R29 Company Deck
0R29 Earnings Call
Q3 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call was strongly positive overall. Intuitive reported broad-based procedure, revenue, system placement and installed-base growth, improving non-GAAP profitability, strong adoption of da Vinci 5 and SP, international expansion, favorable clinical evidence and a substantial product and technology pipeline. The main negatives were slower U.S. da Vinci procedure growth, challenging conditions in China, planned 3% to 5% revenue-per-procedure pressure from pricing actions, higher operating expenses and development costs, a $450 million litigation settlement charge and lower GAAP net income.View all GB:0R29 earnings summaries0R29 Revenue Breakdown
67.72% U.S.
32.28% Outside of U.S
0R29 Stock 12 Month Forecast
Average Price Target
$498.26
▲(33.98% Upside)